Dan-dan Zhao
Guangdong Provincial Key Laboratory Of New Drug Design And Evaluation
Guangzhou, 510006, China
Guangzhou, 510006, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
A novel NAMPT activator ameliorates obesity by repressing ACSL1-dependent lipid synthesis.
Journal: Acta pharmaceutica Sinica. B
Published: September 03, 2025
L-aspartate ameliorates diet-induced obesity by increasing adipocyte energy expenditure.
Journal: Diabetes, obesity & metabolism
Published: July 25, 2024
Development of Novel N-Acylhydrazone Derivatives with High Anti-obesity Activity and Improved Safety by Exploring the Pharmaceutical Properties of Aldehyde Group.
Journal: Journal of medicinal chemistry
Published: July 12, 2024
Design, synthesis and structure-activity relationship of novel 2-pyrimidinylindole derivatives as orally available anti-obesity agents.
Journal: European journal of medicinal chemistry
Published: July 02, 2024
Design, synthesis and evaluation of 2-pyrimidinylindole derivatives as anti-obesity agents by regulating lipid metabolism.
Journal: European journal of medicinal chemistry
Published: July 12, 2023
Design and Synthesis of Bouchardatine Derivatives as a Novel AMP-Activated Protein Kinase Activator for the Treatment of Colorectal Cancer.
Journal: Journal of medicinal chemistry
Published: May 30, 2023
Palladium oxidative addition complex-enabled synthesis of amino-substituted indolyl-4(3H)-quinazolinones and their antitumor activity evaluation.
Journal: Organic & biomolecular chemistry
Published: December 21, 2021
A novel HSF1 activator ameliorates non-alcoholic steatohepatitis by stimulating mitochondrial adaptive oxidation.
Journal: British journal of pharmacology
Published: May 21, 2021
Showing 1-8 of 8
Last Updated: 09/26/2026